10x Genomics Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
10x Genomics (TXG) Misses Q3 EPS by 35c, Revenues Beat
November 10, 2020 4:25 PM EST10x Genomics (NASDAQ: TXG) reported Q3 EPS of ($0.65), $0.35 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $71.8 million versus the consensus estimate of $61.23 million.
Recent Highlights
Revenue was $71.8 million for the third quarter, representing a 17% increase over the... More